Rakesh Dixit
President & Chief Executive Officer Bionavigen
Seminars
Thursday 6th November 2025
Workshop highlights include:
- Contrasting predictive value of CDX and PDX in vivo models, contextualized with time and investment available for preclinical studiesÂ
- Diving into takeaways of ADC translation: what was the most useful results gained from preclinical studies?Â
- Debating considerations for the translation of bispecific ADCs
- Laying out rationale for selecting ADC combinations and delving into preclinical characterization to best predict clinical activity
Tuesday 4th November 2025
Joining the 16th World ADC San Diego Summit Speaker Faculty
